Western Blot: ETV5/ERM Antibody [NBP2-14950] - Non-transfected (-) and transfected (+) 293T whole cell extracts (30 ug) were separated by 10% SDS-PAGE, and the membrane was blotted with ERM antibody diluted at 1:5000. ...read more
Immunocytochemistry/ Immunofluorescence: ETV5/ERM Antibody [NBP2-14950] - HeLa cells were fixed in 4% paraformaldehyde at RT for 15 min. Green: ERM protein stained by ERM antibody diluted at 1:500. Red: Phalloidin, a ...read more
Immunohistochemistry-Paraffin: ETV5/ERM Antibody [NBP2-14950] - Mouse colon. ERM antibody diluted at 1:500. Antigen Retrieval: Citrate buffer, pH 6.0, 15 min
Immunohistochemistry-Paraffin: ERM/Etv5 Antibody [NBP2-14950] - Paraffin-embedded PC14 xenograft, using antibody at 1:100 dilution.
75 kDa. Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors.
The concentration calculator allows you to quickly calculate the volume, mass or concentration of your vial. Simply enter your mass, volume, or concentration values for your reagent and the calculator will determine the rest.
Review this Product
Be the first to review our ETV5/ERM Antibody and receive a gift card or discount.
PRODUCT AVAILABILITY: Update Regarding the Evolving COVID-19 Situation
Bio-Techne appreciates the critical role that you and our products and services play in research efforts to further scientific innovation and discovery. We are continually assessing our manufacturing and supplier capabilities during the COVID-19 situation and are implementing precautionary measures to ensure uninterrupted supply of products and services. Currently, and as we abide by local shelter in place orders across the world, we are fully operational and do not anticipate any material supply disruptions across our Bio-Techne brands and product lines. As the situation evolves, our goal is to utilize preventive measures to reduce the threat that COVID-19 poses to our ability to meet the needs of our customers globally.